Cargando…
Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients?
BACKGROUND: Previous investigations reported inverse relationship between prostate-specific antigen concentration and body mass index (BMI). These results have been explained by a hemodilution effect among obese men. However, the hemodilution of serum carcinoembryonic antigen (CEA) concentration in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649995/ https://www.ncbi.nlm.nih.gov/pubmed/29147433 http://dx.doi.org/10.14740/wjon1026w |
_version_ | 1783272642989522944 |
---|---|
author | Tomita, Masaki Ayabe, Takanori Nakamura, Kunihide |
author_facet | Tomita, Masaki Ayabe, Takanori Nakamura, Kunihide |
author_sort | Tomita, Masaki |
collection | PubMed |
description | BACKGROUND: Previous investigations reported inverse relationship between prostate-specific antigen concentration and body mass index (BMI). These results have been explained by a hemodilution effect among obese men. However, the hemodilution of serum carcinoembryonic antigen (CEA) concentration in obese patients with non-small cell lung cancer (NSCLC) has not been ever reported. METHODS: Consecutive 381 NSCLC patients were enrolled. A body surface area (BSA)-based and a hematocrit (HCT)-based equations were applied for plasma volume (PV) estimation. The relationship between BMI and PV, serum CEA concentration and CEA amount, representing the total amount of CEA protein within the circulation, were examined. RESULTS: Higher BMI was significantly associated with higher PV (P < 0.001). However, serum CEA concentration was not significantly associated with increasing BMI. Furthermore, there was no significant association between BMI and CEA amount. The 5-year survival rate of patients with a high serum CEA concentration was significantly lower than that of patients with a normal CEA. There was no difference in the prognostic significance of serum CEA concentration and CEA amount. CONCLUSIONS: We failed to find the association between BMI and CEA, suggesting no or small hemodilution effect of CEA in NSCLC patients. Furthermore, the measurement of the CEA amount could not provide any additional information. |
format | Online Article Text |
id | pubmed-5649995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56499952017-11-16 Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? Tomita, Masaki Ayabe, Takanori Nakamura, Kunihide World J Oncol Original Article BACKGROUND: Previous investigations reported inverse relationship between prostate-specific antigen concentration and body mass index (BMI). These results have been explained by a hemodilution effect among obese men. However, the hemodilution of serum carcinoembryonic antigen (CEA) concentration in obese patients with non-small cell lung cancer (NSCLC) has not been ever reported. METHODS: Consecutive 381 NSCLC patients were enrolled. A body surface area (BSA)-based and a hematocrit (HCT)-based equations were applied for plasma volume (PV) estimation. The relationship between BMI and PV, serum CEA concentration and CEA amount, representing the total amount of CEA protein within the circulation, were examined. RESULTS: Higher BMI was significantly associated with higher PV (P < 0.001). However, serum CEA concentration was not significantly associated with increasing BMI. Furthermore, there was no significant association between BMI and CEA amount. The 5-year survival rate of patients with a high serum CEA concentration was significantly lower than that of patients with a normal CEA. There was no difference in the prognostic significance of serum CEA concentration and CEA amount. CONCLUSIONS: We failed to find the association between BMI and CEA, suggesting no or small hemodilution effect of CEA in NSCLC patients. Furthermore, the measurement of the CEA amount could not provide any additional information. Elmer Press 2017-04 2017-05-04 /pmc/articles/PMC5649995/ /pubmed/29147433 http://dx.doi.org/10.14740/wjon1026w Text en Copyright 2017, Tomita et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Tomita, Masaki Ayabe, Takanori Nakamura, Kunihide Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title | Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title_full | Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title_fullStr | Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title_full_unstemmed | Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title_short | Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients? |
title_sort | does obesity-related hemodilution of carcinoembryonic antigen exist in non-small cell lung cancer patients? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649995/ https://www.ncbi.nlm.nih.gov/pubmed/29147433 http://dx.doi.org/10.14740/wjon1026w |
work_keys_str_mv | AT tomitamasaki doesobesityrelatedhemodilutionofcarcinoembryonicantigenexistinnonsmallcelllungcancerpatients AT ayabetakanori doesobesityrelatedhemodilutionofcarcinoembryonicantigenexistinnonsmallcelllungcancerpatients AT nakamurakunihide doesobesityrelatedhemodilutionofcarcinoembryonicantigenexistinnonsmallcelllungcancerpatients |